Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Aggressive clinical course of primary invasive vaginal carcinoma associated with type 61 HPV: a case report.

Zanfagnin V, Tripodi E, Perotto S, Ravarino N, Zola P.

Tumori. 2012 Mar-Apr;98(2):57e-58e. doi: 10.1700/1088.11951.

PMID:
22678006
2.

Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.

Shah SM, Drage MG, Lichtman AH, Haddad RI.

J Clin Oncol. 2012 Nov 10;30(32):e321-3. doi: 10.1200/JCO.2012.42.3566. Epub 2012 Sep 24. No abstract available.

PMID:
23008310
3.

[Human papilloma virus and lymphatic metastasis in squamous cell carcinoma of the cervix].

Bakhidze EV, Lavrinovich OE, Chepik OF, Kiselev OI.

Vopr Onkol. 2011;57(3):318-21. Russian.

PMID:
21882602
4.

Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma.

Larsson GL, Helenius G, Andersson S, Sorbe B, Karlsson MG.

Gynecol Oncol. 2013 May;129(2):406-11. doi: 10.1016/j.ygyno.2013.02.004. Epub 2013 Feb 8.

PMID:
23402906
5.

Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina.

Alonso I, Felix A, Torné A, Fusté V, del Pino M, Castillo P, Balasch J, Pahisa J, Rios J, Ordi J.

Gynecol Oncol. 2012 Apr;125(1):194-9. doi: 10.1016/j.ygyno.2011.12.449. Epub 2012 Jan 4.

PMID:
22226684
6.

The prognostic role of human papillomavirus in patients with vaginal cancer.

Brunner AH, Grimm C, Polterauer S, Hefler L, Stani J, Heinze G, Horvat R.

Int J Gynecol Cancer. 2011 Jul;21(5):923-9. doi: 10.1097/IGC.0b013e31821bc615.

PMID:
21666483
7.

Staging for vaginal cancer.

Rajaram S, Maheshwari A, Srivastava A.

Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):822-32. doi: 10.1016/j.bpobgyn.2015.01.006. Epub 2015 Mar 4. Review.

PMID:
25847318
8.

[Prognostic value of human papilloma virus DNA test in patients surgically treated for squamous cell cervical cancer].

Bakhidze EV, Lavrinovich OE, Chepik OF, Kiselev OI.

Vopr Onkol. 2012;58(2):233-7. Russian.

PMID:
22774530
9.

A population-based study of squamous cell vaginal cancer: HPV and cofactors.

Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H.

Gynecol Oncol. 2002 Feb;84(2):263-70.

PMID:
11812085
10.

[Detection of human papilloma virus type 16 in squamous cell carcinoma of colon and its lymph node metastases].

Bognár G, István G, Ledniczky G, Ondrejka P.

Magy Seb. 2008 Aug;61(4):225-9. doi: 10.1556/MaSeb.61.2008.4.3. Hungarian.

PMID:
18799406
11.
12.

Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.

Barzon L, Pizzighella S, Corti L, Mengoli C, Palù G.

J Med Virol. 2002 Jul;67(3):401-5.

PMID:
12116034
13.

Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: a review and summary of the literature.

Jarboe EA, Hunt JP, Layfield LJ.

Diagn Cytopathol. 2012 Jun;40(6):491-7. doi: 10.1002/dc.22837. Epub 2012 Feb 20. Review.

PMID:
22351436
14.

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N; New Technologies for Cervical Cancer Screening Working Group.

J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.

PMID:
18364502
15.

A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.

Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von Knebel Doeberitz M.

Oncogene. 2003 Jun 19;22(25):3977-84.

PMID:
12813471
16.

HPV-positive oropharyngeal cancer: data may justify new approach.

Peres J.

J Natl Cancer Inst. 2010 Oct 6;102(19):1456-9. doi: 10.1093/jnci/djq403. Epub 2010 Sep 24. No abstract available. Erratum in: J Natl Cancer Inst. 2010 Nov 17;102(22):1697.

PMID:
20870975
17.

Rapid progression of primary vaginal squamous cell carcinoma in a young HIV-infected woman.

Lee YC, Holcomb K, Buhl A, Holden J, Abulafia O.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):380-2. Review.

PMID:
10985898
18.

Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.

Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM.

Cancer. 2014 Oct 1;120(19):3082-8. doi: 10.1002/cncr.28831. Epub 2014 Jun 4.

19.

Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia.

Saini R, Tang TH, Zain RB, Cheong SC, Musa KI, Saini D, Ismail AR, Abraham MT, Mustafa WM, Santhanam J.

J Cancer Res Clin Oncol. 2011 Feb;137(2):311-20. doi: 10.1007/s00432-010-0886-8. Epub 2010 Apr 24.

PMID:
20419384
20.

Diagnostic role of detecting HPV in a FNAC of metastatic laterocervical lymph node in a case of occult HPV-related head and neck squamous cell carcinoma.

Ginori A, Scaramuzzino F, Munezero Butorano MA, Barone A, Disanto A.

Pathologica. 2016 Jun;108(2):87-88.

PMID:
28195253

Supplemental Content

Support Center